Treatment of incomplete burst fractures (AO Type A3.1) with dorsal or dorso-ventral proceeding

Randomised controlled trial for treatment of incomplete burst fractures (AO Type A3.1) with dorsal or dorso-ventral proceeding

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN92182348

Enrollment

Registered

2011-03-14

Start date

2009-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A3.1 burst fracture Injury, Occupational Diseases, Poisoning Injury of spinal cord

Interventions

Dorsal or dorso-ventral stabilisation of spine fractures

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 60 years 2. Fracture type A3.1.1 3. Localisation Th11 ? L3 4.Mono-injury

Exclusion criteria

Exclusion criteria: 1. Systemic diseases for example rheumatic diseases,human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), tumor, ankolysing sponylitis (M. Bechterew), etc 2. Osteoporosis (T-Score less than minus 2.5) 3. Polytrauma, multiocular spine injuries 4. No ventral OP possible, pulmonary diseases, obesity (adipositas), already ventral surgery received, etc 5. For study option 2 5.1. Neurologic deficit after spine surgery]

Design outcomes

Primary

Measure	Time frame
1. Pre OP: 1.1. Oswestry Disablity Index 1.2. EQ-5D 1.3. VAS 1.4. Intake of analgesics 1.5. VAS-Spine Score 2. Post OP 3 months/12 months/24 months : 2.1. Oswestry Disablity Index, 2.2. EQ-5D 2.3. VAS 2.4. Intake of analgesics 2.5. VAS-Spine Score 2.6. Odom's criteria	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026